Olympus has built a joint venture with Korea’s Sewon Cellontech under the name of Olympus RMS Co., Ltd. This JV has developed in Japan from autologous tissue a CCI kit (Cultured Chondrocyte Implantation kit), for the treatment of traumatic cartilage defects of the knee joint and transdermable osteochondritis, and will start clinical trials in Japan.

Olympus news release, November 29, 2018